Intracerebral metastases overview: Difference between revisions
No edit summary |
No edit summary |
||
Line 10: | Line 10: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Neurology]] | [[Category:Neurology]] | ||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} |
Revision as of 14:40, 9 November 2015
Intracerebral metastases Microchapters |
Differentiating Intracerebral Metastases from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Intracerebral metastases overview On the Web |
American Roentgen Ray Society Images of Intracerebral metastases overview |
Risk calculators and risk factors for Intracerebral metastases overview |
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Intracerebral metastasis accounts for approximately 25-50% of intracranial tumors in hospitalized patients. The true incidence of brain metastasis is unknown, but recent estimates are as high as 200,000 cases per year in the United States alone. 80% of brain metastases can be accounted for by five primary tumor sites: lung, breast, skin (melanoma), kidney and the gastrointestinal tract. A population-based study of 169,444 cancer patients from 1973 to 2001 in Detroit revealed that overall, 10% of patients diagnosed with one of these five primaries went on to develop brain metastases. Specifically, 19.9% of lung cancers, 6.9% of melanomas, 6.5% of renal cancers, 5.1% of breast cancers and 1.8% of colorectal cancers metastasized to the brain.
Parenchymal blood flow is an important determinant of the distribution of metastases. 80% of metastases localize to the cerebral hemispheres, 15% localize to the cerebellum and 3% localize to the basal ganglia. Often these tumors can be found at the gray/white matter junction.